Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/MERCK-CO-INC-13611/nieuws/Merck-146-s-KEYTRUDA-pembrolizumab-plus-chemotherapie-verbetert-aanzienlijk-de-totale-overlevin-42818500/?utm_source=whatsapp&utm_medium=social&utm_campaign=share